| Literature DB >> 29988993 |
Shoko Mizoguchi1, Kan Katayama1, Tomohiro Murata1, Eiji Ishikawa1, Yuji Kozuka2, Yasuhiro Honda1, Keiko Oda1, Yosuke Hirabayashi1, Takayasu Ito1, Masaaki Ito1.
Abstract
Entities:
Year: 2018 PMID: 29988993 PMCID: PMC6035160 DOI: 10.1016/j.ekir.2018.04.001
Source DB: PubMed Journal: Kidney Int Rep ISSN: 2468-0249
Laboratory data at the first and second admissions
| First | Second | First | Second | ||
|---|---|---|---|---|---|
| Urinary examination | Blood chemistry | ||||
| pH (4.5–7.5) | 7 | 8 | HbA1c (%, 4.9–6.0) | 5.2 | 5.3 |
| Protein (g/gCr) | 1.49 | 1.36 | Glu (mg/dl, 73–109) | 98 | 88 |
| Occult blood | (±) | (–) | TP (g/dl, 6.6–8.1) | 7.9 | 6.7 |
| Glucose (mg/dl) | 250 | 250 | Alb (g/dl, 4.1–5.1) | 4.4 | 3.9 |
| β2mg (μg/l, 5–253) | 42700 | 47456 | BUN (mg/dl, 8–20) | 14 | 13.9 |
| NAG (U/l, 1.0–4.2) | 5.7 | 6.6 | Cr (mg/dl, 0.46–0.79) | 1.56 | 1.46 |
| BJP | (–) | (–) | eGFR (ml/min per 1.73 m2) | 28.1 | 29.7 |
| UA (mg/dl, 2.6–5.5) | 2.2 | 1.9 | |||
| Complete blood count | Na (mEq/l, 138–145) | 139 | 140 | ||
| WBC (/μl, 3300–8600) | 6790 | 9250 | K (mEq/l, 3.6–4.8) | 3.6 | 3.8 |
| RBC (× 104/μl, 386–492) | 454 | 454 | Cl (mEq/l, 101–108) | 112 | 109 |
| Hb (g/dl, 11.6–14.8) | 14.4 | 14.1 | HCO3– (mmol/l) | 18.6 | 17.7 |
| Plt (× 104/μl, 15.8–34.8) | 26.9 | 30 | Ca (mg/dl, 8.8–10.1) | 9.4 | 8.8 |
| IP (mg/dl, 2.7–4.6) | 2.6 | 2.1 | |||
| Serology | AST (U/l, 13–30) | 29 | 19 | ||
| TSH (μU/ml, 0.38–4.31) | 12.43 | 4.75 | ALT (U/l, 7–23) | 29 | 16 |
| fT3 (pg/ml, 1.9–3.8) | 2.4 | 2.7 | LDH (U/l, 124–222) | 232 | 283 |
| fT4 (ng/dl, 0.82–1.63) | 0.76 | 0.96 | ALP (U/l, 106–322) | 517 | 283 |
| ANA | 1:40 | ND | γGTP (U/l, 9–32) | 36 | 31 |
| Anti-M2 (U/ml, <7) | ND | >400 | T. bil (mg/dl, 0.4–1.5) | 0.4 | 0.6 |
| MPO-ANCA (U/ml, 0–8.9) | <1.3 | ND | IgG (mg/dl, 861–1747) | 1180 | 588 |
| PR3-ANCA (U/ml, 0–3.4) | <1.3 | ND | IgA (mg/dl, 93–393) | 95.6 | 71 |
| Anti–SS-A (0–29.9) | <5 | ND | IgM (mg/dl, 50–269) | 890 | 959 |
| Anti–SS-B (0–24.9) | <5 | ND | IgG4 (mg/dl, 4–108) | 55 | ND |
Alb, albumin; ALP, alkaline phosphatase; ALT, alanine transaminase; ANA, antinuclear antibody; AST, aspartate transaminase; β2mg, β2-microglobulin; BJP, Bence Jones protein; BUN, blood urea nitrogen; Ca, calcium; Cl, chloride; Cr, creatinine; eGFR, estimated glomerular filtration rate; fT3, free triiodothyronine; fT4, free thyroxine; Glu, glucose; γ-GTP, γ-glutamyl transpeptidase; Hb, hemoglobin; HbA1c, hemoglobin A1c; HCO3−, bicarbonate ion; IP, inorganic phosphate; K, kalium; LDH, lactate dehydrogenase; MPO-ANCA, myeloperoxidase antineutrophil cytoplasmic antibody; Na, natrium; NAG, N-acetyl-β-D-glucosaminidase; ND, not done; Plt, platelets; PR3-ANCA, proteinase3−antineutrophil cytoplasmic antibody; RBC, red blood cells; T. bil, total bilirubin; TP, total protein; TSH, thyroid stimulating hormone; UA, uric acid; WBC, white blood cells.
Figure 1(a) Renal histology findings on the first and the second admissions. Periodic acid−Schiff (PAS) staining showed severe lymphocyte infiltration in the tubulointerstitial area accompanied by tubular atrophy at the first admission, and the infiltration in the tubulointerstitial area was not improved at the second admission. IgM-positive cells were dominantly observed than IgG-positive cells in the tubulointerstitial area. Bars = 100 μm. (b) Hepatic histology findings at the second admission. Hematoxylin and eosin (HE) staining of a liver biopsy specimen showed inflammatory cell infiltration surrounding the bile ducts at a low magnification and epithelioid granuloma formation at a high magnification. Although there were many IgM-positive cells, IgG-positive cells were scarce. Bars = 100 μm.
Figure 2At the first admission, CD3-positive cells were mixed with CD20- or CD138-positive cells in the tubulointerstitial area. CD138-positive cells were more abundant in the tubulointerstitial area than CD20-positive cells. At the second admission, CD3-positive cells were more dominantly observed than CD20- or CD138-positive cells in the tubulointerstitial area. In the liver, CD3-positive cells were mixed with CD20- or CD138-positive cells in the inflammatory cell infiltrates. Bars = 100 μm.
Summary of the reported cases of tubulointerstitial nephritis with primary biliary cirrhosis
| Age/sex | U-β2mg (μg/l) | U-NAG (U/l) | Urine pH | sCr (mg/dl) | AST (U/l) | ALT (U/l) | ALP (U/l) | γGTP (U/l) | IgM (mg/dl) | AMA | M2A | FS | OM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Macdougall | 50/F | NA | NA | NA | 2 | NA | NA | 117 | NA | 630 | 800 | NA | x | x |
| Kodama | 36/F | NA | NA | NA | 0.8 | 19 | 14 | 83 | 32 | 1260 | 640 | (−) | o | x |
| Lino | 51/F | 25 mg/24 h | NA | 6.5 | 1.8 | 41 | 67 | 107 | 53 | NA | NA | 800 | o | o |
| Lino | 68/F | 57 mg/24 h | NA | 6 | 1.3 | 25 | 34 | 276 | 51 | NA | NA | 640 | o | o |
| Terrier | 42/F | 263,000 | NA | NA | 1.3 | 3N | 2N | 4.5N | 3.5N | 358 | NA | 200 | o | o |
| Komatsuda | 36/F | 10,595 | NA | 7.3 | 0.8 | 19 | 14 | 83 | 32 | 1260 | 640 | (−) | o | x |
| Komatsuda | 66/F | 84,400 | 21.1 | 6.3 | 1.5 | 20 | 10 | 290 | 13 | 663 | 80 | 178 | o | x |
| Komatsuda | 77/F | 15,586 | 2.5 | 7 | 1.4 | 32 | 19 | 152 | 37 | 74 | 20 | 40 | x | x |
| Komatsuda | 52/F | 60,000 | 7.4 | 7.5 | 1.5 | 25 | 19 | 812 | 24 | 665 | 320 | 157 | o | x |
| Bansal | 46/F | NA | NA | NA | 2.3 | NA | NA | 209 | 252 | NA | (+) | (+) | x | x |
| Iwakura | 46/F | 20,975 | 11.1 | NA | 1.1 | 38 | 50 | 694 | 190 | 966 | 160 | 143 | x | x |
| Rasolzadegan | 28/F | NA | NA | NA | 2 | 185 | 138 | NA | 698 | NA | (−) | 19.5 | x | x |
| Yamaguchi | 49/F | NA | NA | 6 | 1.4 | 23 | 24 | 663 | 18 | 1084 | NA | 10 | o | o |
| Takahashi | 44/F | 69,359 | NA | NA | 1.4 | NA | NA | 1559 | 56 | 1284 | NA | 562 | o | x |
| Takahashi | 56/F | 66,987 | NA | NA | 2.7 | NA | NA | 806 | 178 | 2045 | (−) | 10 | o | x |
| Present case | 57/F | 47,456 | 6.6 | 8 | 1.5 | 19 | 16 | 283 | 31 | 959 | 40 | 400 | o | x |
ALP, alkaline phosphatase; ALT, alanine transaminase; AMA, anti-mitochondrial antibody; AST, aspartate transaminase; F, female; FS, Fanconi syndrome; γGTP, γ-glutamyl transpeptidase; M, male; M2A, anti-mitochondrial M2 antibody, NA, not available; OM, osteomalacia; pat, patient; sCr, serum creatinine; U-β2mg, urinary β2-microglobulin; U-NAG, urinary N-acetyl-β-D-glucosaminidase; o, yes; x, no.
Summary of the outcome data for the reported cases of tubulointerstitial nephritis with primary biliary cirrhosis
| Prednisolone (mg) | Follow-up period | Final sCr (mg/dl) | Relapse | |
|---|---|---|---|---|
| Macdougall | 40 | 11 mo | 1.9 | Yes |
| Kodama | NA | NA | NA | NA |
| Lino | 0.5/kg | 1 yr | 1.6 | No |
| Lino | 0.5/kg | NA | 2.3 | No |
| Terrier | 1/kg | 3 mo | 1.1 | No |
| Komatsuda | 25–30 | 16 yr | 0.6 | No |
| Komatsuda | 25–30 | 11 yr | 1.7 | No |
| Komatsuda | 25–30 | 1 yr | 1.5 | No |
| Komatsuda | 25–30 | 0.5 yr | 1 | No |
| Bansal | 40 | 5 mo | NA | No |
| Iwakura | NU | NA | NA | NA |
| Rasolzadegan | NA | 2 yr | NA | No |
| Yamaguchi | 20 | 1 yr | NA | No |
| Takahashi | 20 | 0.8 yr | 1.4 | No |
| Takahashi | 30 | 0.2 yr | 2 | No |
| Present case | Methylprednisolone 500 mg ×3 | 2 yr | 1.3 | No |
NA, not available; NU, not used; pat, patient; sCr, serum creatinine.